vs
Dominari Holdings Inc.（DOMH）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
RHYTHM PHARMACEUTICALS, INC.的季度营收约是Dominari Holdings Inc.的1.9倍（$57.3M vs $30.1M），RHYTHM PHARMACEUTICALS, INC.净利率更高（-83.0% vs -438.1%，领先355.1%），Dominari Holdings Inc.同比增速更快（220.4% vs 36.9%），过去两年Dominari Holdings Inc.的营收复合增速更高（369.1% vs 48.5%）
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
DOMH vs RYTM — 直观对比
营收规模更大
RYTM
是对方的1.9倍
$30.1M
营收增速更快
DOMH
高出183.5%
36.9%
净利率更高
RYTM
高出355.1%
-438.1%
两年增速更快
DOMH
近两年复合增速
48.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $30.1M | $57.3M |
| 净利润 | $-131.8M | $-47.5M |
| 毛利率 | — | 91.6% |
| 营业利润率 | -8.9% | -82.2% |
| 净利率 | -438.1% | -83.0% |
| 营收同比 | 220.4% | 36.9% |
| 净利润同比 | -12426.2% | -9.6% |
| 每股收益（稀释后） | $-6.94 | $-0.73 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOMHRYTM
| Q4 25 | $30.1M | $57.3M | ||
| Q3 25 | $50.8M | $51.3M | ||
| Q2 25 | $34.1M | $48.5M | ||
| Q1 25 | $8.1M | $32.7M | ||
| Q4 24 | $9.4M | $41.8M | ||
| Q3 24 | $4.0M | $33.3M | ||
| Q2 24 | $6.2M | $29.1M | ||
| Q1 24 | $1.4M | $26.0M |
净利润DOMHRYTM
| Q4 25 | $-131.8M | $-47.5M | ||
| Q3 25 | $125.2M | $-52.9M | ||
| Q2 25 | $16.6M | $-46.6M | ||
| Q1 25 | $-32.5M | $-49.5M | ||
| Q4 24 | $1.1M | $-43.3M | ||
| Q3 24 | $-4.2M | $-43.6M | ||
| Q2 24 | $-6.1M | $-32.3M | ||
| Q1 24 | $-5.4M | $-141.4M |
毛利率DOMHRYTM
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
营业利润率DOMHRYTM
| Q4 25 | -8.9% | -82.2% | ||
| Q3 25 | -3.1% | -102.6% | ||
| Q2 25 | -57.0% | -93.4% | ||
| Q1 25 | -394.6% | -143.7% | ||
| Q4 24 | 0.4% | -98.6% | ||
| Q3 24 | -79.1% | -132.0% | ||
| Q2 24 | -44.3% | -139.2% | ||
| Q1 24 | -205.2% | -538.7% |
净利率DOMHRYTM
| Q4 25 | -438.1% | -83.0% | ||
| Q3 25 | 246.4% | -103.1% | ||
| Q2 25 | 48.7% | -96.1% | ||
| Q1 25 | -400.5% | -151.4% | ||
| Q4 24 | 11.4% | -103.6% | ||
| Q3 24 | -104.2% | -131.2% | ||
| Q2 24 | -99.1% | -110.9% | ||
| Q1 24 | -398.0% | -544.4% |
每股收益（稀释后）DOMHRYTM
| Q4 25 | $-6.94 | $-0.73 | ||
| Q3 25 | $7.27 | $-0.82 | ||
| Q2 25 | $1.12 | $-0.75 | ||
| Q1 25 | $-3.02 | $-0.81 | ||
| Q4 24 | $0.21 | $-0.71 | ||
| Q3 24 | $-0.67 | $-0.73 | ||
| Q2 24 | $-1.01 | $-0.55 | ||
| Q1 24 | $-0.91 | $-2.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.5M | $388.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $69.4M | $139.1M |
| 总资产 | $112.9M | $480.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOMHRYTM
| Q4 25 | $80.5M | $388.9M | ||
| Q3 25 | $176.2M | $416.1M | ||
| Q2 25 | $28.2M | $291.0M | ||
| Q1 25 | $18.9M | $314.5M | ||
| Q4 24 | $8.2M | $320.6M | ||
| Q3 24 | $7.2M | $298.4M | ||
| Q2 24 | $12.1M | $319.1M | ||
| Q1 24 | $7.1M | $201.2M |
股东权益DOMHRYTM
| Q4 25 | $69.4M | $139.1M | ||
| Q3 25 | $210.2M | $148.8M | ||
| Q2 25 | $88.6M | $-11.9M | ||
| Q1 25 | $42.4M | $18.9M | ||
| Q4 24 | $39.9M | $21.7M | ||
| Q3 24 | $38.3M | $11.2M | ||
| Q2 24 | $42.4M | $39.3M | ||
| Q1 24 | $47.7M | $61.6M |
总资产DOMHRYTM
| Q4 25 | $112.9M | $480.2M | ||
| Q3 25 | $223.4M | $506.9M | ||
| Q2 25 | $109.3M | $372.7M | ||
| Q1 25 | $52.3M | $386.7M | ||
| Q4 24 | $47.1M | $392.3M | ||
| Q3 24 | $43.4M | $363.6M | ||
| Q2 24 | $49.1M | $381.8M | ||
| Q1 24 | $52.2M | $258.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.7M | $-25.4M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DOMHRYTM
| Q4 25 | $22.7M | $-25.4M | ||
| Q3 25 | $-4.9M | $-26.6M | ||
| Q2 25 | $-353.0K | $-23.3M | ||
| Q1 25 | $1.2M | $-40.4M | ||
| Q4 24 | $-16.7M | $-18.8M | ||
| Q3 24 | $-4.7M | $-25.2M | ||
| Q2 24 | $1.4M | $-29.1M | ||
| Q1 24 | $-8.6M | $-40.7M |
现金转化率DOMHRYTM
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
RYTM
暂无分部数据
